Data from multiple sources - Curated by Toby Galbraith - Last updated 06 June 2017

Melanomas of skin

Although it is one of the rarer forms of skin cancer, melanoma is responsible for a disproportionate amount of mortality. Its incidence has been increasing over time, and is

...


Read more on Melanomas of skin

 

 

Latest news articles

Added 1 month ago Drug news

Interim analysis of NCI Phase III study of Yervoy (ipilimumab) in high risk patients with stage III or resectable stage IV melanoma.- BMS

Bristol-Myers Squibb Company announced results of an interim descriptive analysis from an ongoing National Cancer Institute (NCI) Phase III randomized...

Added 4 months ago Drug news

Array BioPharma Inc.,withdraws from the FDA, binimetinib monotherapy for the treatment of NRAS-mutant melanoma.

Array BioPharma Inc. announced that it has withdrawn from the FDA Division of Oncology Products its new drug application (NDA)...

Search all news articles for Melanomas of skin
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Cystic Fibrosis

View disease awareness information, treatment options and European Cystic Fibrosis Society best practice guidelines

Visit Cystic Fibrosis


Hypogonadism

Epidemiology, pathophysiology, diagnosis/treatment guidelines, recent publication summaries and more

Visit Hypogonadism


Guidelines

Melanoma: assessment and management

This guideline covers the assessment and management of melanoma (a type of skin cancer) in children, young people and adults....

Added 1 year ago

Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Cutaneous melanoma is the most common type of melanoma, and UV exposure is one of the main risk factors. The...

Added 2 years ago

Search all guidelines for Melanomas of skin
 

Journal articles

Dabrafenib: a new opportunity for the treatment of BRAF V600-positive melanoma.

Prior to 2011, the 1-year survival rates for patients suffering from advanced or metastatic melanoma was as low as 33%, with a median overall survival of about 9 months. Several chemotherapeutic regimens have been applied ...

Added 2 months ago

Pembrolizumab use for the treatment of advanced melanoma.

Introduction: Until recently, overall long term survival in patients with stage IV melanoma was lower than 10 %. However, the treatment of melanoma has evolved rapidly over the last few years ...

Added 3 months ago

Risk of cumulative toxicity after complete melanoma response with pembrolizumab.

Pembrolizumab is an approved first-line systemic therapy for unresectable metastatic melanoma. Despite the achievement of complete and durable responses in a small subgroup of patients, it is standard practice that ...

Added 3 months ago

Search all journal articles for Melanomas of skin
 

CME

Urgent referrals in dermatology

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
1
Registration required
1
Subscription fee
0

Malignant melanoma: clinical review

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
2
Registration required
1
Subscription fee
0

Developments in melanoma treatment

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
1
Registration required
1
Subscription fee
FREE
Search all CME for Melanomas of skin